Azarga Uranium Corp.

Expert Comments:

	Colin Healey, Haywood Securities (6/24/19) "We are initiating coverage of Azarga Uranium Corp. with a target of CA$0.50 per share and a Buy rating. . .the company is a U.S.-based developer poised to benefit from a potential policy shift on domestic uranium production as well as from developments relating to its flagship Dewey Burdock project."
Gerardo del Real, Junior Mining Monthly (5/31/19) "Azarga Uranium Corp. continues to be one of the best speculations in the uranium space. The company has the flagship, high-grade in situ recovery Dewey Burdock project that boasts excellent economics, it is led by a proven management team that has had serial success in the past uranium bull cycle, both developing and monetizing assets, and it also has some highly prospective assets outside of Dewey Burdock. . .Azarga is a Strong Buy at these levels."
Nick Hodge, Early Advantage (5/23/19) "Azarga Uranium Corp. is a cheap buy. You can buy it at CA$0.23 today. . .we continue to erase the days leading up to Trump's 232 deadline of July 14."
Nick Hodge, Early Advantage (5/6/19) "Azarga Uranium Corp. is one U.S. uranium play that is above its buy under price. . .given the current uranium landscape and catalysts coming, now is a good time to raise those buy under prices. . .the company is a Buy under $0.25."
Uranium Company Receives Hearing Date to Resolve License Contention (5/2/19) The firm believes the new development suggests the issue could be resolved by year-end 2019. read more >
Nick Hodge, Early Advantage (5/2/19) "Azarga Uranium Corp. is moving forward with its Dewey Burdock project. . .the Atomic Safety and Licensing Board has issued an order that allows the U.S. Nuclear Regulatory Commission to set a schedule for a hearing pertaining to the final contention for the project. . .a decision is set to be made on Nov. 29, 2019."
	David Talbot, Eight Capital (4/15/19) "We reaffirm that Azarga Uranium Corp.'s Dewey Burdock is one of the best undeveloped in situ recovery projects in the U.S. Plans are to produce up to 9.7 Mlb over 11 years. . .uranium prices permitting, we could see wellfield deployment as early as 2019."
Azarga Uranium, a Winner With or Without a Section 232 Windfall (4/5/19) Peter Epstein of Epstein Research explains why he sees this company as an attractive way to play uranium in 2019. read more >

More Expert Comments

Gerardo del Real, Junior Mining Monthly (3/31/19) "Azarga Uranium Corp. remains poised for a breakout as we get closer to the Section 232 report due to the president within the next month. . .it's safe to say whatever the administration decides to do, it is likely to have an 'America First' component, which will send shares higher. That recommendation should coincide with the company clearing the last of its permitting hurdles at the flagship Dewey Burdock asset."
Nick Hodge, Early Advantage (3/21/19) "Azarga Uranium Corp. has closed the CA$3M financing. . .it speaks volumes that the company was able to close it so quickly and that the bulk of it was done with institutions. Those institutions paid CA$0.23; you can pay less than that now. . .it remains extremely cheap."
Nick Hodge, Early Advantage (2/14/19) "Azarga Uranium Corp. is moving forward on the permitting front with Dewey Burdock. . .the Nuclear Regulatory Commission (NRC) has upheld the effectiveness of the company's NRC license. There is one remaining contention that is now being worked on."
	Colin Healey, Haywood Securities (7/18/18) "We visited Azarga Uranium Corp.'s flagship, 100%-owned Dewey Burdock in situ recovery uranium project in southwestern South Dakota. . .Dewey Burdock is poised to deliver stock-catalyzing news flow in 2018. . .the company expects to deliver an updated NI 43-101 resource for Dewey Burdock targeting material resource growth, followed by or in conjunction with an updated PEA integrating the additional resources."
Nick Hodge, Nick Hodge's Early Advantage (7/17/18) "Azarga Uranium Corp.'s Dewey Burdock can grow much larger as there are deposits on the project not included in the resource. . .as it stands, the company is undervalued with a market cap of CA$34M, or less than $1/lb uranium. . .it is a Buy."
	David Talbot, Eight Capital (7/16/18) "We were quite impressed after visiting Azarga Uranium Corp.'s Dewey Burdock and Dewey Terrace assets. . .we reaffirm that Dewey Burdock is one of the best undeveloped in situ recovery projects in the U.S. . .a resource update is due in Q3/18, followed by an updated PEA in Q4/18."

Experts Following This Company

	Peter Epstein, CFA – Epstein Research
	Colin Healey, Analyst – Haywood Securities
	Nick Hodge, Founder and president of the Outsider Club – Outsider Club
	David Talbot, Vice President, Senior Analyst – Eight Capital

The information provided above is from analysts, newsletters, the company and other contributors.

Azarga Uranium Corp. is a sponsor of Streetwise Reports. The company's sponsorship fees pay for Streetwise Reports to create and update this "Investor Summary Page," to which links are placed on Streetwise Reports' websites and newsletters. Streetwise Reports does not accept stock for the payment of fees. See disclaimer for more details.

The company description, investing highlights and catalyst calendar on this page were prepared by the company. The Expert Comments and Experts Following This Company sections of this page are compiled by Streetwise Reports. There may be other information about the company that is not placed on this page. Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on this page.

The Expert Opinions above are excerpted from third-party sources not affiliated with or controlled by Streetwise Reports. The statements or opinions expressed in the Expert Opinions above are those of the authors indicated, and Streetwise Reports has not verified the accuracy of material excerpted here. Publications excerpted above may receive payment or sponsorship from the company mentioned.

Streetwise Reports does not provide investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security.Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.

Readers should conduct their own research for all information publicly available concerning the company.